{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:01:51Z","timestamp":1789948911473,"version":"4.0.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,10,24]],"date-time":"2013-10-24T00:00:00Z","timestamp":1382572800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s40272-013-0050-4","type":"journal-article","created":{"date-parts":[[2013,10,23]],"date-time":"2013-10-23T08:33:43Z","timestamp":1382517223000},"page":"123-128","source":"Crossref","is-referenced-by-count":24,"title":["Quality of Life in Children and Adolescents with Autism Spectrum Disorders: What Is Known About the Effects of Pharmacotherapy?"],"prefix":"10.1007","volume":"16","author":[{"given":"Wendy N.","family":"Moyal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Lord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Walkup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,24]]},"reference":[{"key":"50_CR1","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed (text rev.). Washington, DC; 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"50_CR2","doi-asserted-by":"crossref","unstructured":"Murdoch JD, State MW. Recent developments in the genetics of autism spectrum disorders. Curr Opin Genet Dev 2013 Jun;23(3):310-5","DOI":"10.1016\/j.gde.2013.02.003"},{"issue":"4","key":"50_CR3","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1547-5069.2005.00058.x","volume":"37","author":"CE Ferrans","year":"2005","unstructured":"Ferrans CE, Zerwic JJ, Wilbur JE, Larson JL. Conceptual model of health-related quality of life. J Nurs Scholarsh. 2005;37(4):336\u201342.","journal-title":"J Nurs Scholarsh"},{"key":"50_CR4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/adc.84.3.205","volume":"84","author":"C Eiser","year":"2001","unstructured":"Eiser C, Morse R. A review of measures of quality of life for children with chronic illness. Arch Dis Child. 2001;84:205\u201311.","journal-title":"Arch Dis Child"},{"key":"50_CR5","doi-asserted-by":"crossref","unstructured":"Speith LE, Harris CV. Assessment of health-related quality of life in children and adolescents: an integrative review. J Pediatr Psychol 1996;21(2):175\u201393.","DOI":"10.1093\/jpepsy\/21.2.175"},{"key":"50_CR6","unstructured":"Skevington SM, Lotfy M, O\u2019Connell KA; WHOQOL Group. The World Health Organization\u2019s WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual Life Res 2004;13(2):299\u2013310."},{"key":"50_CR7","doi-asserted-by":"crossref","unstructured":"EuroQol Group. EuroQol\u2014a new facility for the measurement of health-related quality of life. Health Policy 1990;16(3):199\u2013208.","DOI":"10.1016\/0168-8510(90)90421-9"},{"key":"50_CR8","doi-asserted-by":"crossref","unstructured":"Tavernor L, Barron E, Rodgers J, McConachie H. Finding out what matters: validity of quality of life measurement in young people with ASD. Child Care Health Dev. 2013 Jul;39(4):592-601","DOI":"10.1111\/j.1365-2214.2012.01377.x"},{"issue":"8","key":"50_CR9","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/11597200-000000000-00000","volume":"30","author":"JM Tilford","year":"2012","unstructured":"Tilford JM, et al. Preference-based health-related Quality of Life outcomes in children with autism spectrum disorders: a comparison of generic instruments. Pharmacoeconomics. 2012;30(8):661\u201379.","journal-title":"Pharmacoeconomics"},{"issue":"5","key":"50_CR10","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00787-012-0263-z","volume":"21","author":"H Cottenceau","year":"2012","unstructured":"Cottenceau H, et al. Quality of life of adolescents with autism spectrum disorders: comparison to adolescents with diabetes. Eur Child Adolesc Psychiatry. 2012;21(5):289\u201396.","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"50_CR11","doi-asserted-by":"crossref","unstructured":"Kamio Y, Inada N, Koyama T. A nationwide survey on Quality of Life and associated factors of adults with high-functioning autism spectrum disorders. Autism. 2013 Jan;17(1):15-26","DOI":"10.1177\/1362361312436848"},{"key":"50_CR12","first-page":"7","volume":"31","author":"I Kamp-Becker","year":"2010","unstructured":"Kamp-Becker I, et al. Health-related quality of life in adolescents and young adults with high functioning autistic-spectrum disorder. Psychosoc Med. 2010;31:7.","journal-title":"Psychosoc Med"},{"issue":"9","key":"50_CR13","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1007\/s10803-010-1140-6","volume":"41","author":"R Khanna","year":"2011","unstructured":"Khanna R, Madhavan SS, Smith MJ, Patrick JH, Tworek C, Becker-Cottrill B. Assessment of health-related QoL among primary caregivers of children with autism spectrum disorders. J Autism Dev Disord. 2011;41(9):1214\u201327.","journal-title":"J Autism Dev Disord"},{"issue":"1","key":"50_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2788.2011.01486.x","volume":"56","author":"PS Samuel","year":"2012","unstructured":"Samuel PS, Rillotta F, Brown I. Review: the development of family quality of life concepts and measures. J Intellect Disabil Res. 2012;56(1):1\u201316.","journal-title":"J Intellect Disabil Res"},{"issue":"2","key":"50_CR15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/1362361311406143","volume":"16","author":"R Khanna","year":"2012","unstructured":"Khanna R, et al. Psychometric properties of the Caregiver Strain Questionnaire (CGSQ) among caregivers of children with autism. Autism. 2012;16(2):179\u201399. doi: 10.1177\/1362361311406143 Epub 2011 Jun 29.","journal-title":"Autism"},{"issue":"4","key":"50_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7525-4-1","volume":"4","author":"H Allik","year":"2006","unstructured":"Allik H, Larsson JO, Smedje H. Health-related quality of life in parents of school-age children with Asperger Syndrome or High-Functioning Autism. Health Qual Life Outcomes. 2006;4(4):1.","journal-title":"Health Qual Life Outcomes"},{"key":"50_CR17","doi-asserted-by":"crossref","unstructured":"Griffith GM, Totsika V, Nash S, Jones RS, Hastings RP. \u201cWe are all there silently coping.\u201d The hidden experiences of parents of adults with Asperger syndrome. J Intellect Dev Disabil 2012;37(3):237\u201347","DOI":"10.3109\/13668250.2012.701729"},{"issue":"11","key":"50_CR18","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1007\/s00127-012-0482-0","volume":"47","author":"BK Ahmedani","year":"2012","unstructured":"Ahmedani BK, Hock RM. Health care access and treatment for children with co-morbid autism and psychiatric conditions. Soc Psychiatry Psychiatr Epidemiol. 2012;47(11):1807.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"11","key":"50_CR19","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1097\/CHI.0b013e3181b76658","volume":"48","author":"RN Marcus","year":"2009","unstructured":"Marcus RN, et al. A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. J Am Acad Child Adolesc Psychiatry. 2009;48(11):1110\u20139.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"50_CR20","doi-asserted-by":"crossref","unstructured":"Marcus RN, et al. Aripiprazole in the treatment of irritability in pediatric patients (aged 6\u201317 years) with autistic disorder: results from a 52-week, open-label study. J Child Adolesc Psychopharmacol. 2011;21(3):229\u201336.","DOI":"10.1089\/cap.2009.0121"},{"issue":"4","key":"50_CR21","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.clinthera.2012.02.023","volume":"34","author":"JW Varni","year":"2012","unstructured":"Varni JW, et al. Effect of aripiprazole 2 to 15\u00a0mg\/d on health-related quality of life in the treatment of irritability associated with autistic disorder in children: a post hoc analysis of two controlled trials. Clin Ther. 2012;34(4):980\u201392.","journal-title":"Clin Ther"},{"issue":"1","key":"50_CR22","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/2040-2392-3-16","volume":"3","author":"E Anagnostou","year":"2012","unstructured":"Anagnostou E. Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial. Mol Autism. 2012;3(1):16.","journal-title":"Mol Autism"},{"key":"50_CR23","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00431-011-1669-1","volume":"171","author":"H Olivie","year":"2012","unstructured":"Olivie H. The medical care of children with autism. Eur J Pediatr. 2012;171:741\u20139.","journal-title":"Eur J Pediatr"},{"issue":"Suppl. 1","key":"50_CR24","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1542\/peds.2009-1878C","volume":"125","author":"T Buie","year":"2010","unstructured":"Buie T, et al. Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics. 2010;125(Suppl. 1):S1\u201318.","journal-title":"Pediatrics"},{"issue":"2","key":"50_CR25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2165\/11316140-000000000-00000","volume":"12","author":"S Miano","year":"2010","unstructured":"Miano S, Ferri R. Epidemiology and management of insomnia in children with autistic spectrum disorders. Paediatr Drugs. 2010;12(2):75\u201384.","journal-title":"Paediatr Drugs"},{"key":"50_CR26","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1542\/peds.2012-0900I","volume":"130","author":"BA Malow","year":"2012","unstructured":"Malow BA, et al. A practice pathway for the identification, evaluation, and management of insomnia in children and adolescents with autism spectrum disorders. Pediatrics. 2012;130:S106\u201324.","journal-title":"Pediatrics"},{"issue":"2","key":"50_CR27","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jaac.2011.11.010","volume":"51","author":"L Scahill","year":"2012","unstructured":"Scahill L, et al. Effects of risperidone and parent training on adaptive functioning in children with pervasive developmental disorders and serious behavioral problems. J Am Acad Child Adolesc Psychiatry. 2012;51(2):136\u201346.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"6","key":"50_CR28","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1176\/appi.ajp.162.6.1142","volume":"162","author":"CJ McDougle","year":"2005","unstructured":"McDougle CJ, et al. Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology. Am J Psychiatry. 2005;162(6):1142\u20138.","journal-title":"Am J Psychiatry"},{"issue":"4","key":"50_CR29","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.biopsych.2006.05.030","volume":"61","author":"E Hollander","year":"2007","unstructured":"Hollander E, et al. Oxytocin increases retention of social cognition in autism. Biol Psychiatry. 2007;61(4):498\u2013503.","journal-title":"Biol Psychiatry"},{"issue":"7","key":"50_CR30","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.biopsych.2009.09.020","volume":"67","author":"AJ Guastella","year":"2010","unstructured":"Guastella AJ, Einfeld SL, Gray KM, Rinehart NJ, Tonge BJ, Lambert TJ, Hickie IB. Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders. Biol Psychiatry. 2010;67(7):692\u20134.","journal-title":"Biol Psychiatry"},{"key":"50_CR31","doi-asserted-by":"crossref","unstructured":"Coury DL et al. Use of psychotropic medication in children and adolescents with autism spectrum disorders. Pediatrics. 2012;130(Suppl. 2):S69\u201376.17","DOI":"10.1542\/peds.2012-0900D"},{"key":"50_CR32","doi-asserted-by":"crossref","unstructured":"Williams K et al. Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders. Cochrane Database Syst Rev. 2010;8:CD004677","DOI":"10.1002\/14651858.CD004677.pub2"},{"issue":"5","key":"50_CR33","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0278-5846(93)90058-Z","volume":"17","author":"MC Dolske","year":"1993","unstructured":"Dolske MC, et al. A preliminary trial of ascorbic acid as supplemental therapy for autism. Prog Neuropsychopharmacol Biol Psychiatry. 1993;17(5):765\u201374.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"50_CR34","doi-asserted-by":"crossref","unstructured":"Nye C, Brice A. Combined vitamin B6-magnesium treatment in autism spectrum disorder. Cochrane Database Syst Rev 2005;(4):CD003497","DOI":"10.1002\/14651858.CD003497.pub2"},{"key":"50_CR35","doi-asserted-by":"crossref","unstructured":"James S et al. Omega-3 fatty acids supplementation for autism spectrum disorders (ASD). Cochrane Database Syst Rev 2011;(11):CD007992","DOI":"10.1002\/14651858.CD007992.pub2"},{"key":"50_CR36","doi-asserted-by":"crossref","unstructured":"Posey DJ et al. A pilot study of D-cycloserine in subjects with autistic disorder. Am J Psychiatry 2004;161:2115\u20137","DOI":"10.1176\/appi.ajp.161.11.2115"},{"issue":"7","key":"50_CR37","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1177\/088307380001500701","volume":"15","author":"RH Sandler","year":"2000","unstructured":"Sandler RH, et al. Short-term benefit from oral vancomycin treatment of regressive-onset autism. J Child Neurol. 2000;15(7):429\u201335.","journal-title":"J Child Neurol"},{"key":"50_CR38","first-page":"204","volume":"55","author":"Centers for Disease Control and Prevention","year":"2006","unstructured":"Centers for Disease Control and Prevention. Deaths associated with hypocalcemia from chelation therapy: Texas, Pennsylvania and Oregon, 2003\u20132005. Morb Mort Wkly Rep. 2006;55:204\u20137.","journal-title":"Morb Mort Wkly Rep"},{"issue":"2","key":"50_CR39","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/mrdd.20062","volume":"11","author":"SE Levy","year":"2005","unstructured":"Levy SE, Hyman SL. Novel treatments for autistic spectrum disorders. Ment Retard Dev Disabil Res Rev. 2005;11(2):131\u201342.","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"50_CR40","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3389\/fnhum.2012.00100","volume":"6","author":"P Whiteley","year":"2012","unstructured":"Whiteley P, et al. Gluten- and casein-free dietary intervention for autism spectrum conditions. Front Hum Neurosci. 2012;6:344. doi: 10.3389\/fnhum.2012.00344 Epub 2013 Jan 4.","journal-title":"Front Hum Neurosci"},{"key":"50_CR41","unstructured":"Institute of Medicine (US) Immunization Safety Review Committee. Immunization safety review: vaccines and autism. Washington, DC: National Academies Press; 2004."},{"issue":"3","key":"50_CR42","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1542\/peds.2004-0434","volume":"114","author":"SK Parker","year":"2004","unstructured":"Parker SK, Schwartz B, et al. Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data. Pediatrics. 2004;114(3):793\u2013804.","journal-title":"Pediatrics"},{"key":"50_CR43","doi-asserted-by":"crossref","unstructured":"van Steensel FJA, B\u00f6gels SM, Dirksen CD. Anxiety and Quality of Life: clinically anxious children with and without autism spectrum disorders compared. J Clin Child Adol Psych 2012;41:6, 731\u20138.","DOI":"10.1080\/15374416.2012.698725"},{"issue":"Suppl. 2","key":"50_CR44","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1542\/peds.2012-0900G","volume":"130","author":"DM Sikora","year":"2012","unstructured":"Sikora DM, Vora P, Coury DL, Rosenberg D. Attention-deficit\/hyperactivity disorder symptoms, adaptive functioning, and quality of life in children with autism spectrum disorder. Pediatrics. 2012;130(Suppl. 2):S91\u20137.","journal-title":"Pediatrics"},{"key":"50_CR45","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJMoa013171","volume":"347","author":"RUPP Autism Network","year":"2002","unstructured":"RUPP Autism Network. Risperidone in children with autism and serious behavioral problems. NEJM. 2002;347:314\u201321.","journal-title":"NEJM"},{"key":"50_CR46","doi-asserted-by":"crossref","unstructured":"Phetrasuwan S, Shandor Miles M. Parenting stress in mothers of children with autism spectrum disorders. J Spec Pediatr Nurs 2009;14(3):157\u201365","DOI":"10.1111\/j.1744-6155.2009.00188.x"},{"key":"50_CR47","first-page":"1","volume":"3","author":"PR Sterzing","year":"2012","unstructured":"Sterzing PR, Shattuck PT, Narendorf SC, Wagner M, Cooper BP. Bullying involvement and autism spectrum disorders: prevalence and correlates of bullying involvement among adolescents with an autism spectrum disorder. Arch Pediatr Adolesc Med. 2012;3:1\u20137.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"50_CR48","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/archpsyc.62.11.1266","volume":"62","author":"RUPP Autism Network","year":"2005","unstructured":"RUPP Autism Network. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Arch Gen Psychiatry. 2005;62:1266\u201374.","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"50_CR49","first-page":"322","volume":"12","author":"CA Jaselskis","year":"1992","unstructured":"Jaselskis CA, et al. Clonidine treatment of hyperactive and impulsive children with autistic disorder. J ClinPsychopharmacol. 1992;12(5):322\u20137.","journal-title":"J ClinPsychopharmacol"},{"issue":"5","key":"50_CR50","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1089\/cap.2006.16.589","volume":"16","author":"L Scahill","year":"2006","unstructured":"Scahill L, et al. A prospective open trial of guanfacine in children with pervasive developmental disorders. J Child Adolesc Psychopharmacol. 2006;16(5):589\u201398.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"50_CR51","doi-asserted-by":"crossref","unstructured":"Arnold LE et al. Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial. J Am Acad Child Adolesc Psychiatry 2006;45(10):1196\u2013205","DOI":"10.1097\/01.chi.0000231976.28719.2a"},{"issue":"5","key":"50_CR52","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1089\/cap.2006.16.599","volume":"16","author":"DJ Posey","year":"2006","unstructured":"Posey DJ, et al. Open-label atomoxetine for attention-deficit\/ hyperactivity disorder symptoms associated with high-functioning pervasive developmental disorders. J Child Adolesc Psychopharmacol. 2006;16(5):599\u2013610.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"50_CR53","doi-asserted-by":"crossref","unstructured":"King BH et al. Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism. Arch Gen Psychiatry 2009;66(6):583\u201390","DOI":"10.1001\/archgenpsychiatry.2009.30"},{"key":"50_CR54","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. (text rev.). Washington, DC; 2000"},{"issue":"7","key":"50_CR55","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s10803-006-0123-0","volume":"36","author":"OT Leyfer","year":"2006","unstructured":"Leyfer OT, Folstein SE, Bacalman S, Davis NO, Dinh E, Morgan J, Tager-Flusberg H, Lainhart JE. Comorbid psychiatric disorders in children with autism: interview development and rates of disorders. J Autism Dev Disord. 2006;36(7):849\u201361.","journal-title":"J Autism Dev Disord"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-013-0050-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40272-013-0050-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-013-0050-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T01:50:53Z","timestamp":1564537853000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40272-013-0050-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,24]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["50"],"URL":"https:\/\/doi.org\/10.1007\/s40272-013-0050-4","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,24]]}}}